{"filings":[{"id":2106048,"accession_number":"0001493152-26-036342","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2026-08-06T20:11:27+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q2 2026 revenue $9.5M (+28% YoY); net loss narrows to $3.1M; raises FY 2026 guidance to >30% growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $9.5M, up 28% YoY from $7.4M; GAAP net loss $3.1M ($0.33/share) vs $3.7M ($0.44) prior year.","Adjusted EBITDA net loss improved 26% to $1.8M from $2.4M.","Quell product line sales $1.3M, up ~700% YoY; Truvaga revenue $1.3M, up 27% YoY.","VA channel: Rx gammaCore revenue up 11% YoY; ~16,400 VA patients (2.7% penetration of addressable headache market).","Company raises FY 2026 revenue guidance to >30% year-over-year growth; targets positive Adjusted EBITDA in Q3 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93633,"accession_number":"0001493152-26-021493","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q1 revenue $9.6M (+43% YoY); reaffirms ~30% FY2026 growth guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $9.6M, record quarterly revenue, up 43% from $6.7M Q1 2025.","GAAP net loss $5.3M ($0.59 per share); includes $1.9M leadership transition expenses.","Adjusted EBITDA net loss improved 24% YoY to $2.3M from $3.1M.","VA prescription gammaCore revenue grew 26% YoY; Quell Fibromyalgia quarterly sales >$1M.","Michael Fox appointed COO in April 2026; Truvaga launched in UK in January 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":9584000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105426,"accession_number":"0001493152-26-011620","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2026-03-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore FY2025 revenue $32M (+27% YoY); CEO Goldberger to retire","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $32.0M, up 27% YoY; US Rx +25%, general wellness +97%.","GAAP net loss $14.0M ($1.65/share) vs $11.9M loss prior year.","Adjusted EBITDA net loss $8.7M vs $9.0M; cash $11.6M at Dec 2025.","FY2026 guidance: ~30% annual revenue growth over 2025.","CEO Dan Goldberger retiring Apr 1; CFO Lev interim President; Michael Fox named COO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105425,"accession_number":"0001493152-26-002847","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"electroCore prelim FY2025 rev $31.8-32.0M (+26%); Q4 rev ~$9.0-9.2M (+30%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary FY2025 revenue $31.8–$32.0M, ~26% growth over FY2024 of $25.2M.","Q4 2025 revenue $9.0–$9.2M, ~30% growth over Q4 2024.","Cash, cash equivalents, and marketable securities ~$11.6M at Dec 31, 2025 (vs $13.2M Sep 30, 2025).","Company will provide detailed operational and financial update in March 2026 earnings call."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":32032000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121706,"accession_number":"0001493152-25-020878","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q3 net sales $8.7M up 33% YoY; raises FY2025 revenue guidance to $31.5-$32.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $8.7M, 33% increase YoY; YTD net sales $22.8M, up 26% vs first nine months of 2024.","Net loss $3.4M ($0.40 per share) vs $2.5M loss in Q3 2024; adjusted EBITDA net loss $2.0M vs $2.1M.","FY2025 revenue guidance raised to $31.5-$32.5M; expects first quarter of positive adjusted EBITDA in H2 2026.","Total cash $13.2M at Sep 30, 2025, up from $12.2M at Dec 31, 2024.","Prescription devices sales $6.81M (+19% YoY); health & wellness $1.88M (+121% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":22789000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121705,"accession_number":"0001493152-25-016869","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"electroCore issues 360,737 shares at $5.145 to settle legal fee obligations","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["360,737 shares issued at $5.145 per share to settle outstanding legal fees owed to investors.","No cash proceeds received; shares issued directly in satisfaction of debt.","Private placement closed October 2, 2025; resale registration to be filed within 90 days.","Company agreed to indemnify purchasers for certain liabilities under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138386,"accession_number":"0001641172-25-026318","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-09-03T23:59:59+00:00","items":["5.02","5.07","7.01","9.01"],"status":"ready","headline":"electroCore appoints Microsoft healthcare head Elena Bonfiglioli to board; declassification fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elena Bonfiglioli, Microsoft Global Business Leader Healthcare, appointed to board effective Sept 2, 2025.","Dr. Thomas Errico appointed Chairman, succeeding Peter Cuneo who retired.","Annual meeting: Board declassification proposal failed; 94.6% of votes cast in favor but only 14.05% of outstanding shares voted.","Three Class I directors re-elected: Daniel Goldberger, Julie Goldstein, Patricia Wilber.","Ratification of CBIZ CPAs as auditor and advisory say-on-pay approved at annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138385,"accession_number":"0001641172-25-022427","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q2 2025 revenue up 20% to $7.4M; net loss widens to $3.7M; raises $7.2M debt","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $7.4M in Q2 2025, up 20% YoY ($6.1M); YTD sales $14.1M up 22%.","GAAP net loss $3.7M ($0.44 loss per share) vs $2.7M ($0.38 loss) in Q2 2024.","Cash and securities $7.4M at June 30; raised $7.2M via term debt on Aug 4, 2025.","Full year 2025 revenue guidance ~$30.0M; net cash usage remainder of year $3.9-4.4M.","VA Rx gammaCore sales up 13% to $5.2M; Truvaga up 74% to $994K; Quell VA added $114K."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":14100000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138384,"accession_number":"0001641172-25-019883","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K/A","filed_at":"2025-07-16T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"electroCore amends 8-K: NeuroMetrix acquisition deemed not significant; no financials required","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Filed 8-K/A on July 16, 2025 to amend the May 2, 2025 original report on the NeuroMetrix merger.","Company determined, after SEC staff consultation, that NURO is not a 'significant subsidiary' under Reg S-X.","As a result, audited and pro forma financial statements for NURO are not required under Item 9.01.","Merger closed on May 1, 2025 with NURO surviving as a wholly owned subsidiary of electroCore."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155832,"accession_number":"0001641172-25-009039","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q1 revenue up 23% to $6.7M; net loss $3.9M; guides FY25 revenue ~$30M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2025 revenue $6.7M (+23% YoY); GAAP net loss $3.9M ($0.47 loss per share).","Adjusted EBITDA net loss $3.1M vs $3.2M in Q1 2024.","Cash & equivalents $8.0M at Mar 31, 2025 (down from $12.2M at Dec 2024).","FY 2025 revenue guidance ~$30.0M; expected net cash use $3.8-$4.3M for next 3 quarters.","Closed NeuroMetrix acquisition; Quell contributed ~$170k in Q1 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":6719000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155831,"accession_number":"0001641172-25-008177","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["2.01","7.01","8.01","9.01"],"status":"ready","headline":"electroCore completes acquisition of NeuroMetrix; $4.49/share plus CVRs","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Cash consideration of $4.49 per NURO share; each share also gets one CVR tied to Quell sales milestones.","CVR payments include 8% of Quell Net Sales up to $500K in first year, 6% in second year, plus DPNCheck proceeds.","electroCore gains Quell Fibromyalgia Solution, expects to leverage VA Hospital System distribution channel.","NURO shares to be de-listed from Nasdaq Capital Market before trading on May 2, 2025.","Transaction approved by NURO stockholders on March 21, 2025; closed May 1, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155830,"accession_number":"0001193805-25-000419","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"electroCore replaces auditor Marcum LLP with CBIZ CPAs after attest business acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP resigned as independent registered public accounting firm on April 1, 2025; CBIZ CPAs P.C. engaged for FY 2025.","Change follows CBIZ CPAs' acquisition of Marcum's attest business effective November 1, 2024.","No disagreements with Marcum on accounting principles; prior material weakness in internal controls (Sept 30, 2023) has been remediated.","Marcum furnished a letter to the SEC (Exhibit 16.1) agreeing with the 8-K statements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174299,"accession_number":"0001213900-25-023217","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-03-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore FY2024 revenue $25.2M (+57% YoY); net loss narrows to $11.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2024 net sales of $25.2M, up 57% from $16.0M in 2023, driven by 85% growth in VA channel and 174% increase in Truvaga.","GAAP net loss $11.9M ($1.59 EPS) vs $18.8M ($3.42 EPS) in 2023; Adjusted EBITDA net loss $9.0M vs $15.4M.","Gross margin improved to 85% from 83%; cash and securities $12.2M at Dec 31, 2024 vs $10.6M a year ago.","Operating expenses $33.6M, up slightly from $32.5M; R&D down to $2.4M from $5.3M on reduced Truvaga Plus development.","Company cites pending acquisition of NeuroMetrix as part of inorganic expansion strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174298,"accession_number":"0001193805-25-000253","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Charles S. Theofilos resigns from electroCore Board; Board size reduced to seven","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Charles S. Theofilos, M.D. resigned as Class III director and from Compensation and Nominating/Governance Committees effective Feb 24, 2025.","Board decreased its size from eight to seven members effective Feb 28, 2025.","Resignation effective immediately; no reason disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174297,"accession_number":"0001193805-25-000048","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2025-01-17T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"electroCore reports preliminary Q4 2024 revenue of $7.07M and FY2024 revenue of $25.2M","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Preliminary net revenue for Q4 2024: $7.07 million.","Preliminary net revenue for FY2024: $25.2 million.","Cash, restricted cash, cash equivalents, and marketable securities as of Dec 31, 2024: $12.2 million.","Results are unaudited and provided for upcoming investor presentations."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":25182000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191249,"accession_number":"0001193805-24-001481","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-12-17T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"electroCore to acquire NeuroMetrix in cash+CVR merger valuing NURO at net cash plus milestones","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["NURO shareholders receive pro rata share of net cash (min $8M condition) and one CVR per share.","CVR pays up to ~$500K/yr based on 8% Quell Net Sales (Yr1) and 6% (Yr2), plus DPNCheck proceeds.","Voting agreements cover ~6.3% of NURO shares; NURO pays $500K termination fee in certain cases.","Closing requires NURO stockholder approval, FY2024 10-K filing, net cash >$8M, and no material adverse effect.","Deal must close by June 15, 2025; either party can terminate if not consummated by then."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191248,"accession_number":"0001193805-24-001420","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-11-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"electroCore enters $20M ATM offering with H.C. Wainwright","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ATM agreement allows sale of up to $20M of common stock at market prices.","3.0% commission to Wainwright; net proceeds for sales/marketing and working capital.","Shares sold via Nasdaq at-the-market; no obligation to sell any shares.","Offering under existing effective S-3 registration statement; prospectus supplement filed.","Agreement date November 29, 2024; can be terminated by either party at any time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191247,"accession_number":"0001213900-24-097484","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q3 revenue $6.6M, +45% YoY; net loss narrows to $2.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q3 revenue of $6.6M, up 45% from $4.5M in Q3 2023; Rx gammaCore VA/DoD sales +75% to $4.8M.","GAAP net loss improved 38% to $2.5M from $4.0M; diluted EPS -$0.31 vs -$0.68.","Adjusted EBITDA net loss of $2.1M vs $3.0M; Truvaga sales surged 147% to $0.66M.","Cash and marketable securities $13.2M as of Sep 30, 2024, up from $10.6M at Dec 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":18136000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207719,"accession_number":"0001193805-24-001098","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-09-06T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"ElectroCore CFO Brian Posner retiring Oct 4, 2024; Joshua Lev appointed CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Posner retiring effective Oct 4 for personal/family reasons; will provide consulting services for 12 months.","Joshua Lev, previously Chief Strategy Officer, appointed CFO effective Oct 4; base salary $415k, bonus target 40%.","Lev's severance period under Executive Severance Policy increased to 12 months with a severance multiple of 1.0.","Annual meeting results: directors Gandolfo and Theofilos elected; Marcum LLP ratified as auditor; compensation advisory votes passed.","Say-on-frequency vote favored 1 year; board determined to hold advisory vote on executive compensation annually."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207718,"accession_number":"0001213900-24-066120","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q2 net sales $6.1M (+73% YoY); net loss narrows to $2.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Seventh consecutive record quarterly revenue of $6.1M, up 73% YoY from $3.6M.","GAAP net loss of $2.7M vs $4.9M in Q2 2023; adjusted EBITDA loss of $1.9M vs $4.5M.","VA/DoD channel sales surged 120% to $4.6M; Truvaga up 97% to $572K.","Raised ~$9.0M via registered direct offering and concurrent private placements.","Launched Truvaga Plus app-enabled wellness product and next-gen TAC-STIM."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":11582000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207717,"accession_number":"0001193805-24-000934","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Peter Cuneo reclassified to Class I; to become consultant after 2025 board term","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["F. Peter Cuneo resigned as Class III director and reappointed as Class I director, term expiring at 2025 Annual Meeting.","He will not stand for reelection at 2025 meeting and will then serve as consultant to CEO for one year.","Granted option to purchase 50,000 shares at $6.43/share, vesting monthly over 12 months.","Consulting fee: $500/hour or $3,000/day for days over 6 hours; expenses reimbursed.","Change is not due to any disagreement; Chairman role continues until 2025 meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225192,"accession_number":"0001193805-24-000740","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-06-03T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"electroCore raises $9.3M in equity/warrant offering with $5.645M from insiders","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$9.3M from registered direct & private placements; directors/officers invested $5.645M.","Securities: 225K registered pre-funded warrants + 112.5K warrants; private placement: 1,208,310 shares/pre-funded warrants + 604,150 warrants.","Combined effective price $6.4925/share+1/2 warrant; warrants exercise at $6.43, expire in 5 years.","Net proceeds used for sales/marketing, working capital, and general corporate purposes.","Offerings priced at market under Nasdaq rules; expected to close June 5, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225191,"accession_number":"0001213900-24-040873","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q1 net sales up 96% to record $5.4M; GAAP loss narrows to $0.53/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q1 net sales of $5.4M, up 96% from $2.8M in Q1 2023; driven by VA/DoD (+127%) and Truvaga (+162%).","GAAP net loss of $3.5M ($0.53 loss per share) vs $5.9M ($1.24 loss per share) in Q1 2023.","Adjusted EBITDA net loss improved to $3.1M from $5.1M in Q1 2023; gross margin held at 84%.","Cash, cash equivalents and restricted cash $8.1M vs $10.6M at Dec 31, 2023.","Launched DTC Truvaga Plus app-enabled wellness product during the quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":5443000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244422,"accession_number":"0001213900-24-022169","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-03-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore reports FY2023 revenue $16.0M, up 87% YoY; Q4 revenue $5.2M, up 103%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2023 net sales of $16.0M, up 87% from $8.6M; Q4 net sales $5.2M, up 103% from $2.6M.","GAAP net loss improved to $18.8M from $22.2M; Adjusted EBITDA net loss narrowed to $15.4M from $19.0M.","VA/DoD channel drove growth: $9.6M revenue, +89% YoY; Truvaga and TAC-STIM combined $2.8M, up sharply.","Gross margin improved to 83% from 81%; net cash used in operations $14.7M vs $16.6M.","Cash and equivalents $10.6M at year-end vs $18.0M; raised $7.5M in July 2023 registered direct offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":244421,"accession_number":"0001193805-24-000047","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2024-01-16T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"electroCore issues preliminary unaudited financial estimates for Q4 and FY 2023","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Management will use presentation with select preliminary revenue estimates; results subject to audit and may change.","No specific financial figures included in the 8-K filing; details in attached exhibit not reproduced here.","Company plans to present to investors and analysts; no guidance or commentary on actual performance provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261860,"accession_number":"0001193805-23-001596","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-12-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"electroCore appoints Dr. Charles Theofilos to Board; board expands to eight members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Theofilos appointed as Class III director effective Dec. 8, 2023; board size increased from 7 to 8.","Theofilos is a retired neurosurgeon and founder of several healthcare companies, including a predecessor to electroCore.","He will receive standard non-employee director compensation and an inaugural equity grant effective Jan. 1, 2024.","His spouse's entity, Happy Holstein Management, participated in the Company's August 2023 registered direct offering and private placement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261859,"accession_number":"0001193805-23-001531","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-11-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"electroCore holds analyst day webinar on vagus nerve stimulation therapy","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Analyst day webinar conducted on November 21, 2023; presentation attached as Exhibit 99.1.","No specific financial results, guidance, or material operational updates were disclosed in the filing.","The webinar focused on the company's vagus nerve stimulation technology and platform."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261858,"accession_number":"0001213900-23-084755","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q3 2023 revenue $4.5M (+128% YoY); raises FY23 guidance to $15-15.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q3 net sales of $4.5M, a 128% increase from $2.0M in Q3 2022.","VA/DoD prescription revenue grew 135% YoY to $2.7M; US commercial up 12%.","GAAP net loss narrowed to $4.0M from $5.5M; adjusted EBITDA loss $3.0M from $4.8M.","Full-year 2023 revenue guidance raised to $15.0-15.5M (prior $14-15M).","Cash, equivalents & restricted cash $13.7M at Sept 30; raised $7.5M net in July offering."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.87,"consensus_revenue_estimate":null,"consensus_revenue_actual":10839000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279023,"accession_number":"0001213900-23-065038","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-08-09T23:59:59+00:00","items":["2.02","9.01","5.02","5.07"],"status":"ready","headline":"electroCore Q2 revenue $3.6M (+65% YoY); board shrinks to 7; raises $7.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q2 revenue $3.6M, +65% YoY; GAAP net loss $4.9M vs $5.3M prior year.","Adjusted EBITDA net loss $4.5M vs $4.9M in Q2 2022.","Raised ~$7.5M in registered direct offering; pro forma cash $16.2M as of June 30.","Board reduced to 7 members; Joseph Errico resigned May 2023, Trevor Moody not reelected.","Reiterates FY2023 revenue guidance of $14M-$15M."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":6331000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279022,"accession_number":"0001193805-23-001031","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-07-31T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"electroCore raises ~$8.1M in registered direct offering and private placements priced at $4.4125/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds to electroCore expected to be approximately $8.145 million before fees and expenses.","Combined effective offering price of $4.4125 per share and one-half warrant; warrants exercisable at $4.35.","Includes 169,968 shares sold to certain officers and directors in a concurrent private placement.","Closing expected on or about August 2, 2023; net proceeds for sales & marketing, working capital.","Company had $8.7M cash as of June 30, 2023; offering nearly doubles pro forma cash balance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":279021,"accession_number":"0001193805-23-000968","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-07-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore reports record Q2 2023 revenue of ~$3.55M, up 65% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record quarterly revenue of ~$3.55M (preliminary unaudited) for Q2 2023, +65% vs Q2 2022.","Government channel revenue (VA/DoD) grew ~75% to ~$2.085M; 138 facilities now purchasing.","US commercial cash-pay prescribers grew to 2,225 (from 660 a year ago); revenue ~$430K.","Truvaga net revenue ~$291K (vs $147K in Q1 2023); TAC-STIM revenue ~$311K.","Reaffirmed FY 2023 revenue guidance of $14.0-$15.0M; net cash used ~$3.5M in Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":6331000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":297348,"accession_number":"0001193805-23-000800","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-05-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Joseph Errico resigns from electroCore Board, becomes Science & Strategic Advisor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph P. Errico resigned from the Board and all committees on May 22, 2023; departure not due to any disagreement.","He entered a three-year consulting agreement as Science and Strategic Advisor to the CEO, effective May 22, 2023.","Compensation: $10,000/month for up to 20 hours plus $500/hour or $3,000/day for additional hours.","He may attend Board meetings as non-voting observer through May 22, 2024 at CEO's discretion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":297347,"accession_number":"0001213900-23-035982","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-05-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q1 2023 net sales $2.8M (+46% YoY); GAAP net loss $5.9M; guides FY23 revenue $14-15M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q1 revenue of $2.8M vs $1.9M in Q1 2022, a 46% increase across all major channels.","GAAP net loss $5.9M vs $5.6M; adjusted EBITDA loss $5.1M vs $4.6M; cash $12.2M (Dec 2022: $18.0M).","Truvaga contributed $147K in first full quarter; Rx gammaCore VA/DoD up 38% to $1.7M; US commercial up 56%.","FY 2023 revenue guidance reiterated at $14-15M; expects legacy headache channels to grow >50% to at least $12M.","Net cash usage in Q1 was $5.9M, up from $4.8M; company expects cash usage to decrease through the year."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":2780000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":297346,"accession_number":"0001193805-23-000568","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-04-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore expects record Q1 2023 revenue of ~$2.8M, up 46% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q1 revenue ~$2.8M, 46% increase over $1.9M in Q1 2022.","Government channel revenue ~$1.8M (+42% YoY); 124 VA/DoD facilities now purchasing.","U.S. commercial revenue ~$581K (+74% YoY); Truvaga contributed ~$147K in first full quarter.","International revenue ~$406K (+33% YoY), includes ~$45K license fees from Teijin.","FY 2023 revenue guidance reiterated at $14.0-15.0 million."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":2780000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317701,"accession_number":"0001213900-23-018557","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-03-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore reports record FY2022 net sales of $8.6M, up 58%; guides FY2023 revenue $14-15M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record full-year net sales of $8.6M (+58% YoY); Q4 net sales $2.6M (+72% YoY).","GAAP net loss $22.2M vs $17.2M in 2021; Adjusted EBITDA loss $19.0M vs $15.8M.","Cash and equivalents $18.0M at Dec 31, 2022, down from $34.7M at Dec 31, 2021.","FY2023 guidance: revenue $14-15M; legacy headache channels >$12M; new Truvaga/TAC-STIM >$2M.","Launched Truvaga wellness product and TAC-STIM under Air Force program; distribution deal with Joerns."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317700,"accession_number":"0001193805-23-000242","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-02-23T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"electroCore receives Nasdaq extension to March 13, 2023 to regain bid price compliance after reverse stock split","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders approved reverse stock split on Feb 13, 2023; implemented Feb 15, 2023.","Nasdaq Hearings Panel granted extension until March 13, 2023 to regain compliance with Bid Price Rule.","Panel noted company likely to regain compliance by March 1, 2023 after reverse split.","Decision subject to continued compliance and possible review by Nasdaq Listing and Hearing Review Council."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317699,"accession_number":"0001193805-23-000223","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-02-14T23:59:59+00:00","items":["3.03","5.03","5.07","7.01","9.01"],"status":"ready","headline":"electroCore announces 1-for-15 reverse stock split to regain Nasdaq compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split effective 12:01 a.m. ET on Feb 15, 2023; shares reduced from ~71.2M to ~4.74M.","Stockholders approved split range of 1-for-5 to 1-for-50 at Feb 13 special meeting; Board set 1-for-15.","Company appealed Nasdaq delisting notice (Dec 20, 2022) for bid price non-compliance; hearing held Feb 2, 2023.","Fractional shares will be cashed out based on Feb 14, 2023 closing price; CUSIP changes to 28531P202.","Option and warrant exercise prices adjusted proportionately; par value remains $0.001 per share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317698,"accession_number":"0001193805-23-000052","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2023-01-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore reports record Q4 revenue of $2.5M; FY2022 revenue $8.5M, up 57% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q4 2022 revenue ~$2.5M (+68% YoY); full-year 2022 revenue ~$8.5M (+57% YoY).","Government channel revenue ~$5.1M (+56% YoY); 117 VA/DoD military treatment facilities using gammaCore.","U.S. commercial revenue ~$1.7M (+158% YoY); launched TAC-STIM Air Force BOOST and Truvaga wellness.","Cash & equivalents ~$18.0M at Dec 31, 2022 vs $21.9M at Sep 30, 2022; cash burn.","International revenue ~$1.6M (+7% YoY); includes $139K license fees from Teijin in Japan."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":8592000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335967,"accession_number":"0001193805-22-001785","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-12-23T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"ElectroCore receives Nasdaq delisting notice for bid price deficiency; seeks reverse stock split approval","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter on Dec 20, 2022 for failing minimum $1 bid price for 10 consecutive trading days.","Company will request a hearing; trading stays paused until hearing decision.","Filed proxy for special meeting on Feb 13, 2023 to authorize reverse stock split.","If hearing not requested by Dec 27, trading suspended Dec 29 and delisting proceeds.","No assurance of continued listing; may trade on OTC Markets if delisted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335966,"accession_number":"0001193805-22-001663","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-12-07T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"electroCore declares dividend of Series A Preferred Stock with super voting rights to facilitate reverse stock split","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Each common share receives one one-thousandth of a share of Series A Preferred; record date Dec 19, 2022.","Each share of Series A Preferred has 1,000,000 votes; voting limited to reverse stock split proposals only.","Series A votes are cast proportionally with common stock votes, effectively boosting holder voting power on reverse split.","Preferred shares are non-transferable except with common, have no dividend rights, and a $0.001 liquidation preference.","Unvoted shares are redeemed for $0.01 per 10 whole shares (rounded down to nearest multiple of ten thousand)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335965,"accession_number":"0001193805-22-001644","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-12-05T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"ElectroCore annual meeting results: three directors elected, reverse split fails","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors Goldberger, Wilber, Goldstein elected with ~83-88% of votes cast.","Marcum LLP ratification approved: 33.4M for, 2.5M against, 0.7M abstain.","Reverse stock split proposal failed: only 40.67% of outstanding shares voted in favor, below required majority.","Outstanding shares entitled to vote: 71.2M; quorum of 36.6M shares present."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335964,"accession_number":"0001213900-22-069015","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-11-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q3 revenue $2.0M (+33% YoY); net loss widens to $5.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $2.0M (+33% YoY); VA/DoD $1.15M, US Commercial $0.41M, OUS $0.37M.","GAAP net loss $5.5M vs $4.0M loss; Adjusted EBITDA loss $4.8M vs $3.1M loss.","Cash $21.9M at Sep 30, down from $34.7M at Dec 31, 2021; Q3 cash used $4.6M.","Q4 2022 guidance: revenue $2.2-2.3M, net cash usage $4.0-4.5M.","Gross margin improved to 87% (76% in Q3 2021) on licensing model and higher ASP."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":6032000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335963,"accession_number":"0001193805-22-001417","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-10-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q3 2022 revenue ~$2.0M, up 33% YoY; cash $21.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2022 revenue approximately $1,976,000, a 33% increase over Q3 2021 revenue of $1,487,000.","Government channels (VA/DoD) revenue ~$1,148,000, up 21% YoY; 113 military treatment facilities now purchasing gammaCore.","Commercial channel revenue ~$411,000, up ~160% YoY driven by cash pay initiatives.","International revenue ~$416,000, up 9% YoY, including $45,000 in license fees from Teijin Limited for Japan.","Cash and cash equivalents $21.9M at September 30, 2022, down from $26.6M at end of Q2 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":6032000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353369,"accession_number":"0001193805-22-001286","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-09-20T23:59:59+00:00","items":["5.08","8.01","9.01"],"status":"ready","headline":"electroCore sets 2022 annual meeting for Dec 2; proposal deadline Sept 30","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual meeting to be held virtually on December 2, 2022.","Proxy materials expected to be sent in October 2022.","Stockholder proposals for Rule 14a-8 inclusion due by Sept 30, 2022.","Director nominations and other business outside Rule 14a-8 also due Sept 30, 2022.","Meeting date changed by more than 30 days from 2021 meeting anniversary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353368,"accession_number":"0001213900-22-044771","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-08-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q2 2022 revenue $2.2M (+70% YoY); GAAP net loss $5.3M; gross margin 83%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2.2M, up 70% YoY and 14% sequentially; VA/DoD $1.19M (+52.6% YoY), US Commercial $501K (+381.7%).","GAAP net loss $5.3M; Adjusted EBITDA loss $4.9M; net cash used in ops $3.2M, improved from $4.8M in Q1 2022.","Gross margin 83% vs 71% a year ago; cash $26.6M at June 30, down from $34.7M at Dec 31, 2021.","Q3 2022 outlook: net revenue expected near Q2 levels; net cash usage $4.5M-$5.0M.","gammaCore selected for DoD BOOST program; exclusive license with Teijin for Japan."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":4056000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":353367,"accession_number":"0001193805-22-001093","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-07-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore guides Q2 2022 revenue at least $2.1M, up 65% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record quarterly revenue of at least $2.1M, up ~65% from Q2 2021 and ~11% from Q1 2022.","Government channels revenue ~$1.2M, up 54% YoY; 106 VA/DoD facilities purchasing gammaCore.","Commercial revenue ~$465K, up 68% QoQ and 347% YoY, driven by cash-pay initiatives.","International revenue ~$466K, up 53% QoQ; includes $50K license fees from Teijin in Japan.","Cash and cash equivalents ~$26.6M as of June 30, down from $29.9M at March 31, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":4056000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371081,"accession_number":"0001193805-22-000992","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-06-23T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"electroCore listing transferred to Nasdaq Capital Market; gets 180-day grace period for bid price rule","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Approval received June 22, 2022; transfer effective June 23, 2022 under same ticker ECOR.","Noncompliant with Nasdaq $1.00 bid price rule since Dec 20, 2021; original deadline June 20, 2022.","Nasdaq granted additional 180 days until Dec 19, 2022 to regain compliance with $1.00 bid for 10 consecutive days.","Company may implement reverse stock split if necessary to meet bid price requirement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371077,"accession_number":"0001193805-22-000742","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K/A","filed_at":"2022-05-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"electroCore assigns new directors to board committees; Goldstein to Nominating, Wilber to Audit","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["On May 5, 2022, Board appointed Julie Goldstein to Nominating and Corporate Governance Committee and Patricia Wilber to Audit Committee.","Audit Committee: Chair Thomas M. Patton, Michael G. Atieh, John P. Gandolfo, Patricia Wilber.","Nominating and Corporate Governance Committee: Chair Thomas J. Errico, F. Peter Cuneo, Julie Goldstein.","Compensation Committee: Chair Trevor J. Moody, Thomas J. Errico, John P. Gandolfo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371080,"accession_number":"0001213900-22-024265","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"electroCore Q1 revenue $1.9M, up 58% YoY; net loss $5.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.9M, up 58% from Q1 2021 and 27% sequentially.","GAAP net loss $5.6M; adjusted EBITDA net loss $4.6M.","Cash and equivalents $29.9M at March 31, 2022; operating cash used $4.8M.","Q2 2022 guidance: revenue at least $1.9M; cash used ~$3.5M.","FDA Breakthrough Device for PTSD; exclusive Japan license with Teijin."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":1899000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":371079,"accession_number":"0001193805-22-000699","cik":1560258,"company_name":"electroCore, Inc.","ticker":"ECOR","form_type":"8-K","filed_at":"2022-04-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Michael G. Atieh resigns from electroCore board effective June 8, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael G. Atieh, Class I director, resigns effective June 8, 2022.","Resignation not due to any disagreement with company operations or policies.","Board size reduced from ten to nine members upon resignation.","Atieh's term was to last until the 2022 annual meeting; early departure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":75573886.15584415,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-04-29T23:59:59+00:00|371079"}